At a glance
ClinicalIndex Comparison RecordN/ACompleted· 490 enrolled
Drug / intervention
No Interventionother
Likely dose
Not stated in record
Key inclusion· 6
- ✓Cough lasting ≥2 weeks
- ✓At least one additional TB clinical symptom (fever, weight loss, appetite loss, hemoptysis, dyspnea, chest pain, night sweats, or fatigue)
- ✓Chest X-ray findings suggestive of TB per pulmonologist or internist with pulmonology consultation
- ✓Age ≥18 years
Key exclusion· 4
- ✕Pregnancy
- ✕Serious liver disease
- ✕Chronic kidney disease
- ✕Psychiatric illness that might interfere with study compliance
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Tuberculosis Research of INA-RESPOND On Drug Resistance
In Brief
An observational study evaluating No Intervention for Lung Tuberculosis and MDR TB. Completed, enrolled 490 participants across 7 sites.
Detailed Summary
This study is a prospective observational cohort study of TB patients who are treated or evaluated at 10 study sites. Patients presenting with cough for 2 weeks or longer with at least one additional TB symptom and a chest X-ray suggestive of TB, will be invited to be enrolled in the study. The signed informed consent will designate their willingness to participate on this study.
Study Details
Study Typeobservational
Allocation--
Masking--
Primary Purpose--
ConditionsLung Tuberculosis, MDR TB
CountriesIndonesia
Timeline
N/ACompletedFinished
2017201820192020202120222023202420252026
First PostedMay 2016
Enrollment StartFeb 2017
Primary CompletionNov 2018
Study CompletionApr 2021
TodayJul 2026
First PostedMay 2, 2016
Enrollment StartFeb 13, 2017
Primary CompletionNov 30, 2018
Study CompletionApr 26, 2021
TodayJul 2, 2026
Enrollment to primary: 1.8 yearsPosted 10.2 years ago
Interventions
No Interventionother
No Intervention